LINCOLN PHARMACEUTICALS
Back to Balance Sheet
|
LINCOLN PHARMACEUTICALS Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹131 Cr | ₹117 Cr | ₹96 Cr | ₹111 Cr | ₹95 Cr |
What is the latest Total Current Liabilities ratio of LINCOLN PHARMACEUTICALS ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹131 Cr |
| Mar2024 | ₹117 Cr |
| Mar2023 | ₹96 Cr |
| Mar2022 | ₹111 Cr |
| Mar2021 | ₹95 Cr |
How is Total Current Liabilities of LINCOLN PHARMACEUTICALS Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹131 Cr | 11.65 | |
| Mar2024 | ₹117 Cr | 22.29 | |
| Mar2023 | ₹96 Cr | -13.27 | |
| Mar2022 | ₹111 Cr | 16.80 | |
| Mar2021 | ₹95 Cr | - | |
Compare Total Current Liabilities of peers of LINCOLN PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LINCOLN PHARMACEUTICALS | ₹1,235.8 Cr | 0.3% | 36.3% | 7.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹415,613.0 Cr | 0.9% | 6.2% | 0.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹167,105.0 Cr | 1.8% | 4.8% | 6.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹145,926.0 Cr | 1.3% | 9.8% | 37.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹109,088.0 Cr | 1.7% | 5.8% | 6.7% | Stock Analytics | |
| CIPLA | ₹107,120.0 Cr | -1.3% | 0.9% | -8.9% | Stock Analytics | |
LINCOLN PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LINCOLN PHARMACEUTICALS | 0.3% |
36.3% |
7.7% |
| SENSEX | 0% |
1.2% |
9.7% |
You may also like the below Video Courses